DAY 1 | Auditorium |
|
DAY 1 | Auditorium |
| ||
08:00 | 08:00 | |||
08:05 | 08:05 | |||
08:10 | 08:10 | |||
08:15 | 08:15 | |||
08:20 | 08:20 | |||
08:25 | 08:25 | |||
08:30 | Registration | 08:30 | ||
08:35 | 08:35 | |||
08:40 | 08:40 | |||
08:45 | 08:45 | |||
08:50 | 08:50 | |||
08:55 | 08:55 | |||
09:00 | 09:00 | |||
09:05 | 09:05 | |||
09:10 | 09:10 | |||
09:15 | 09:15 | |||
09:20 | 09:20 | |||
09:25 | 09:25 | |||
09:30 | 09:30 | |||
09:35 | 09:35 | |||
09:40 | Antisense Based Therapeutics for the Treatment of Neurological Diseases 09:40 (45 mins) Frank Bennett, Ionis Pharmaceuticals |
09:40 | ||
09:45 | 09:45 | |||
09:50 | 09:50 | |||
09:55 | 09:55 | |||
10:00 | 10:00 | |||
10:05 | 10:05 | |||
10:10 | 10:10 | |||
10:15 | 10:15 | |||
10:20 | 10:20 | |||
10:25 | 10:25 | |||
10:30 | 10:30 | |||
10:35 | 10:35 | |||
10:40 | 10:40 | |||
10:45 | 10:45 | |||
10:50 | 10:50 | |||
10:55 | Refreshment Break | 10:55 | ||
11:00 | 11:00 | |||
11:05 | 11:05 | |||
11:10 | 11:10 | |||
11:15 | 11:15 | |||
11:20 | 11:20 | |||
11:25 | 11:25 | |||
11:30 | Session Introduction 11:30 (5 mins) Pär Matsson, University of Gothenburg In vitro Safety Assessment of Antisense Oligonucleotide Drugs 11:35 (30 mins) Sabine Sewing, Hoffmann-La Roche Technology Spotlight Partner 12:05 (5 mins) Vendor Sponsor, ELRIG Harnessing RNA-protein binding for nucleic acids therapeutics design improvement 12:10 (30 mins) Alice Ghidini, Sixfold Technology Spotlight Partner 12:40 (5 mins) Vendor Sponsor, ELRIG Revealing the intracellular concentration of nucleic-acid based therapeutics using NanoSIMS 12:45 (30 mins) Michael Kurczy, AstraZeneca |
11:30 | ||
11:35 | 11:35 | |||
11:40 | 11:40 | |||
11:45 | 11:45 | |||
11:50 | 11:50 | |||
11:55 | 11:55 | |||
12:00 | 12:00 | |||
12:05 | 12:05 | |||
12:10 | 12:10 | |||
12:15 | 12:15 | |||
12:20 | 12:20 | |||
12:25 | 12:25 | |||
12:30 | 12:30 | |||
12:35 | 12:35 | |||
12:40 | 12:40 | |||
12:45 | 12:45 | |||
12:50 | 12:50 | |||
12:55 | 12:55 | |||
13:00 | 13:00 | |||
13:05 | 13:05 | |||
13:10 | 13:10 | |||
13:15 | 13:15 | |||
13:20 | Refreshment Break | 13:20 | ||
13:25 | 13:25 | |||
13:30 | 13:30 | |||
13:35 | 13:35 | |||
13:40 | 13:40 | |||
13:45 | 13:45 | |||
13:50 | 13:50 | |||
13:55 | 13:55 | |||
14:00 | 14:00 | |||
14:05 | 14:05 | |||
14:10 | 14:10 | |||
14:15 | 14:15 | |||
14:20 | 14:20 | |||
14:25 | 14:25 | |||
14:30 | Therapeutic siRNAs: how do we find the “best” ones? 14:30 (45 mins) Marie Wikstrom Lindholm, Silence Therapeutics Gmbh Technology Spotlight Partner 15:15 (5 mins) Vendor Sponsor, ELRIG Charge neutral modifications to enhance the cell uptake and activity of exon-skipping oligonucleotides 15:20 (30 mins) Tom Brown, Oxford University |
14:30 | ||
14:35 | 14:35 | |||
14:40 | 14:40 | |||
14:45 | 14:45 | |||
14:50 | 14:50 | |||
14:55 | 14:55 | |||
15:00 | 15:00 | |||
15:05 | 15:05 | |||
15:10 | 15:10 | |||
15:15 | 15:15 | |||
15:20 | 15:20 | |||
15:25 | 15:25 | |||
15:30 | 15:30 | |||
15:35 | 15:35 | |||
15:40 | 15:40 | |||
15:45 | 15:45 | |||
15:50 | 15:50 | |||
15:55 | Refreshment Break | 15:55 | ||
16:00 | 16:00 | |||
16:05 | 16:05 | |||
16:10 | 16:10 | |||
16:15 | 16:15 | |||
16:20 | 16:20 | |||
16:25 | 16:25 | |||
16:30 | Tricyclo-DNA: promising antisense oligonucleotides for the treatment of neuromuscular diseases 16:30 (30 mins) Aurelie GOYENVALLE, Inserm - University of Versailles Industry Insider Presentation 17:00 (15 mins) Vendor Sponsor, ELRIG Thermodynamic nearest-neighbor parameters for LNA/DNA PS-ASOs binding to RNA 17:15 (30 mins) Peter Hagedorn, Roche |
16:30 | ||
16:35 | 16:35 | |||
16:40 | 16:40 | |||
16:45 | 16:45 | |||
16:50 | 16:50 | |||
16:55 | 16:55 | |||
17:00 | 17:00 | |||
17:05 | 17:05 | |||
17:10 | 17:10 | |||
17:15 | 17:15 | |||
17:20 | 17:20 | |||
17:25 | 17:25 | |||
17:30 | 17:30 | |||
17:35 | 17:35 | |||
17:40 | 17:40 | |||
17:45 | 17:45 | |||
17:50 | 17:50 | |||
17:55 | 17:55 | |||
18:00 | 18:00 | |||
18:05 | 18:05 | |||
18:10 | 18:10 | |||
18:15 | 18:15 | |||
18:20 | 18:20 | |||
18:25 | 18:25 | |||
18:30 | 18:30 | |||
18:35 | 18:35 | |||
18:40 | 18:40 | |||
18:45 | 18:45 | |||
18:50 | 18:50 | |||
18:55 | 18:55 | |||
19:00 | 19:00 |